サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1661103

子宮内避妊器具（IUD）市場レポート：製品別、最終用途別、地域別、2025年～2033年

Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 148 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
子宮内避妊器具（IUD）市場レポート：製品別、最終用途別、地域別、2025年～2033年
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮内避妊器具の世界市場規模は2024年に47億米ドルに達しました。今後、IMARC Groupは、2033年には68億米ドルに達し、2025～2033年の成長率（CAGR）は3.87％になると予測しています。同市場は、長時間作用型可逆的避妊（LARC）に対する意識の高まり、IUDのデザインや挿入技術における著しい技術進歩、家族計画や避妊へのアクセスを促進する政府の好意的な取り組みによって推進されています。

子宮内避妊器具（IUD）は、長期的で可逆的な避妊法の一形態であり、今日利用可能な最も効果的な避妊法の一つです。IUDは小さなT字型の器具で、医療従事者が子宮に挿入して妊娠を防ぎます。少量の銅を放出して精子が卵子に到達するのを阻止する銅製IUDと、ホルモンを放出して子宮頸管粘液を濃くし、精子が卵子と受精するのを阻止するホルモン性IUDです。IUDは、種類にもよりますが、3年から10年という長い保護期間を提供します。IUDは最小限のケアで済むという利便性があり、その有効性、可逆性、使いやすさから支持されています。

世界市場の主な原動力は、効果的で長期的な避妊法が利用できるようになったことで、リプロダクティブヘルス（性と生殖に関する健康）に対する意識が高まっていることです。これに伴い、可逆的で手間のかからない避妊方法への嗜好が高まっていることも、市場に弾みをつけています。さらに、IUDの利点や使用方法に関するヘルスケアプロバイダーや組織による支援や教育的イニシアチブは、市場の重要な成長促進要因として作用しています。これに加えて、IUDの安全性と信頼性による医療専門家による推奨が、市場の拡大を促しています。また、家族計画やリプロダクティブヘルス教育を推進する政府のイニシアチブの高まりも、市場にプラスの影響を与えています。さらに、有利なヘルスケア政策と保険適用が市場を牽引しており、IUDをより多くの人々にとってより身近で手ごろなものにしています。

子宮内避妊器具（IUD）市場傾向／促進要因：

人口抑制傾向の高まり

持続可能な開発に対する意識の高まりから、政府や国際機関は人口抑制への取り組みを優先するようになった。政策の方向性が大きく転換したことで、IUDのような効果的かつ長期的な避妊法の役割が強化されつつあります。また、いくつかの国の政府機関、NGO、製造業者による様々な協力プログラムが、IUDを好ましい家族計画法として普及させることを目指しています。このような提携は、しばしば広範なキャンペーン、流通網、教育的アウトリーチをもたらし、IUDをより身近で多様な人々に受け入れられるものにしています。さらに、様々な地域に合わせた介入や補助金によって、IUDの普及はさらに促進されています。責任ある家族計画と生殖に関する選択に重点を置いた、人口抑制に向けたこの世界の動きは、IUD市場の強力な推進力として、需要と革新の両方に拍車をかけています。

高まる女性の労働参加

女性の労働参加率の上昇は文化的・経済的な変化を示し、生殖の選択を含む生活の様々な側面に影響を与えます。女性が専門的な役割を担うようになるにつれ、便利で信頼性が高く、メンテナンスの少ない避妊法へのニーズが高まっています。IUDは、長期間の有効性と最小限の継続的なケアで知られ、働く女性のライフスタイルのニーズに共鳴しています。IUDは、キャリアと私生活を両立させるために多くの人が求める柔軟性と確実性を提供します。さらに、雇用主やヘルスケア・プロバイダーはこうしたニーズをますます認識し、包括的な医療給付の一環としてIUDのサポートや保険適用を提供しています。このように、増加する人口層の現実の需要と市場の供給が一致することは、単なる動向ではなく、IUD市場の実質的な原動力となっています。

医療技術と研究の絶え間ない進歩

ヘルスケア産業は、医療技術と研究の絶え間ない進歩によって特徴付けられており、避妊の分野も例外ではないです。素材、デザイン、ホルモン供給メカニズムにおける革新は、より高度で使いやすいIUDの開発につながった。改良の原動力となっているのは、この分野の主要企業による研究開発への投資であり、多くの場合、ヘルスケアプロバイダーや研究機関との共同研究です。このようなパートナーシップにより、ユーザーのニーズ、嗜好、医学的要件をより深く理解することが可能になり、新しいIUDモデルのデザインと機能性の指針となっています。このように技術革新に注力することで、IUDは避妊技術の最前線にあり続け、効果的であるだけでなく、ユーザーの快適さと幸福に沿った選択肢を提供することができます。技術進歩への投資は、リプロダクティブヘルス（性と生殖に関する健康）の向上へのコミットメントを強調するものであり、IUD市場成長の極めて重要な原動力となっています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の子宮内避妊器具市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品別
  • 市場内訳：最終用途別
  • 市場内訳：地域別
  • 市場予測
  • SWOT分析
    • 概要
    • 強み
    • 弱み
    • 機会
    • 脅威
  • バリューチェーン分析
    • 概要
    • 研究開発
    • 原材料調達
    • 製造
    • マーケティング
    • 流通
    • 最終用途
  • ポーターのファイブフォース分析
    • 概要
    • 買い手の交渉力
    • 供給企業の交渉力
    • 競合の程度
    • 新規参入業者の脅威
    • 代替品の脅威

第6章 市場内訳：製品別

  • ホルモン子宮内避妊器具
    • 市場動向
    • 市場予測
  • 銅製子宮内避妊器具
    • 市場動向
    • 市場予測

第7章 市場内訳：最終用途別

  • 病院
    • 市場動向
    • 市場予測
  • 婦人科クリニック
    • 市場動向
    • 市場予測
  • コミュニティヘルスケア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • アジア太平洋地域
  • 北米
  • 欧州
  • 中東・アフリカ
  • ラテンアメリカ

第9章 子宮内避妊器具の製造工程

  • 製品概要
  • 原材料要件
  • 製造工程
  • 主要成功要因とリスク要因

第10章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Actavis
    • Bayer
    • Teva Pharmaceuticals
    • Allergan
    • ANI Pharmaceuticals
    • Eurogine
    • OCON Medical
    • Pregna
    • SMB Corporation
    • HLL Lifecare
    • HRA Pharma
    • Besins HealthCare
図表

List of Figures

  • Figure 1: Global: Intrauterine Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Intrauterine Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Intrauterine Devices Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Intrauterine Devices Market: Breakup by End-Use (in %), 2024
  • Figure 5: Global: Intrauterine Devices Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Intrauterine Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Intrauterine Devices Industry: SWOT Analysis
  • Figure 8: Global: Intrauterine Devices Industry: Value Chain Analysis
  • Figure 9: Global: Intrauterine Devices Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intrauterine Devices (Hormonal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Intrauterine Devices (Hormonal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Intrauterine Devices (Copper) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Intrauterine Devices (Copper) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Intrauterine Devices (End-Use in Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Intrauterine Devices (End-Use in Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Intrauterine Devices (End-Use in Community Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Intrauterine Devices (End-Use in Community Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Intrauterine Devices (Other End-Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Intrauterine Devices (Other End-Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Europe: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Europe: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Asia Pacific: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Asia Pacific: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Middle East and Africa: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Middle East and Africa: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Latin America: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Latin America: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Intrauterine Devices Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intrauterine Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Intrauterine Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Intrauterine Devices Market Forecast: Breakup by End-Use (in Million USD), 2025-2033
  • Table 4: Global: Intrauterine Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Intrauterine Devices Manufacturing: Raw Material Requirements
  • Table 6: Global: Intrauterine Devices Market: Competitive Structure
  • Table 7: Global: Intrauterine Devices Market: Key Players
目次
Product Code: SR112025A954

The global intrauterine devices market size reached USD 4.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.8 Billion by 2033, exhibiting a growth rate (CAGR) of 3.87% during 2025-2033. The market is propelled by the rising awareness about long-acting reversible contraception (LARC), significant technological advancements in IUD design and insertion techniques, favorable government initiatives promoting family planning and contraception access.

Intrauterine Devices (IUDs) are a form of long-term, reversible birth control, representing one of the most effective contraceptive methods available today. An IUD is a small, T-shaped device that is inserted into the uterus by a healthcare provider to prevent pregnancy. There are two main types of IUDs: copper IUDs, which release a small amount of copper to deter sperm from reaching the egg, and hormonal IUDs, which release hormones to thicken cervical mucus and block sperm from fertilizing the egg. IUDs provide an extended period of protection, ranging from three to ten years, depending on the type. They offer the convenience of minimal ongoing care and are favored for their efficacy, reversibility, and ease of use.

The global market is primarily driven by the increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods. In line with this, the growing preference for reversible and hassle-free birth control options is also providing an impetus to the market. Moreover, the support and educational initiatives by healthcare providers and organizations about the benefits and usage of IUDs are acting as significant growth-inducing factors for the market. In addition to this, the endorsement of IUDs by medical professionals, owing to their safety and reliability, is encouraging the expansion of the market. Also, the rise in government initiatives promoting family planning and reproductive health education is impacting the market positively. The market is further driven by favorable healthcare policies and insurance coverage, which make IUDs more accessible and affordable to a broader population.

Intrauterine Devices (IUD) Market Trends/Drivers:

Rising trend of population control efforts

The growing awareness of sustainable development has led governments and international organizations to prioritize population control efforts. This significant shift in policy direction is reinforcing the role of effective and long-term contraceptive methods such as IUDs. Also, various collaborative programs among governmental bodies of several countries, NGOs, and manufacturers aim to promote IUDs as a preferred method of family planning. These alliances often result in extensive campaigns, distribution networks, and educational outreach, making IUDs more accessible and acceptable to diverse populations. Additionally, tailored interventions and subsidies in various regions further facilitate the adoption of IUDs. This global movement towards population control, with an emphasis on responsible family planning and reproductive choices, stands as a powerful driver for the IUD market, fueling both demand and innovation.

Growing female workforce participation

The rise in the female workforce's participation marks a cultural and economic shift, influencing various aspects of life, including reproductive choices. As women continue to take on professional roles, the need for convenient, reliable, and low-maintenance contraceptive methods has grown. IUDs, known for their extended effectiveness and minimal ongoing care, resonate with the lifestyle needs of working women. They provide the flexibility and assurance that many seek in balancing their careers and personal lives. Moreover, employers and healthcare providers are increasingly recognizing these needs, offering support and coverage for IUDs as part of comprehensive health benefits. This alignment of market supply with the real-life demands of a growing segment of the population is not just a trend but a substantial driving force in the IUD market.

Continual advancements in medical technology and research

The healthcare industry is marked by continuous advancements in medical technology and research, and the field of contraception is no exception. Innovations in materials, designs, and hormone delivery mechanisms have led to the development of more advanced and user-friendly IUDs. The drive for improvement is fueled by investment in research and development by leading companies in the field, often in collaboration with healthcare providers and research institutions. These partnerships enable a deeper understanding of user needs, preferences, and medical requirements, guiding the design and functionality of new IUD models. This focus on innovation ensures that IUDs remain at the forefront of contraceptive technology, offering choices that are not only effective but also aligned with the comfort and well-being of users. The investment in technological progress underscores the commitment to enhancing reproductive health, making it a pivotal driver in the IUD market growth.

Intrauterine Devices (IUD) Industry Segmentation:

Breakup by Product:

  • Hormonal Intrauterine Device
  • Copper Intrauterine Device

Hormonal intrauterine device (IUD) represents the largest market segment

The demand for hormonal IUDs is growing due to their high effectiveness in preventing pregnancies, which makes them a reliable choice for many. Their suitability for extended usage of up to 3-7 years offers long-term solutions without the need for daily intervention. The ability to return to normal fertility after removal adds to their appeal. Many users also find them to be a preferable non-surgical option, contributing to their popularity. The combined factors of effectiveness, longevity, reversibility, and non-surgical nature make this segment an integral part of the global IUD market.

On the other hand, copper IUDs offer a contraceptive method without the use of hormones, appealing to those who want to avoid hormonal intervention. They provide a cost-effective solution, often entailing only a one-time expense. The protection they offer is long-lasting, often effective for up to 10 years, making them an attractive long-term option. These factors together make copper IUDs a significant segment, reflecting the various preferences and financial considerations of the global population.

Breakup by End-Use:

  • Hospitals
  • Gynaecology Clinics
  • Community Healthcare
  • Others

In the hospitals segment, the availability of specialized professionals ensures access to expert care, while the use of modern tools and technologies facilitates insertion. Comprehensive services, including consultation, insertion, and follow-up, create a streamlined patient experience. Hospitals continue to be a core setting for IUD administration, integrating specialized care with state-of-the-art technology to serve a broad population base.

On the other hand, gynaecology clinics are seeing growth in IUD administrations owing to their focused expertise in women's reproductive health. They offer personalized care tailored to individual needs and are often more accessible than hospitals for many patients. This specialized, accessible, and personalized care makes gynaecology clinics an essential part of the landscape, serving a diverse clientele with varying needs and preferences.

Furthermore, community healthcare segment of the market is impelled by the introduction of affordable and often lower-cost services. Accessibility in remote and underserved areas ensures that more people can avail themselves of these devices. Education and outreach are significant components of this segment, with community health providers offering necessary information and support. This approach fosters a wider reach and makes IUDs available to populations that might otherwise have limited access.

Breakup by Region:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest intrauterine devices (IUD) market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The North America region's IUD market is driven by several factors, forming a complex and synergistic landscape that fosters growth. The well-developed healthcare infrastructure ensures robust availability and service delivery, making both hormonal and copper IUDs accessible to a wide range of the population.

Regulatory support in this region fosters a generally favorable environment for IUDs, with clear guidelines and standards that help maintain quality and safety. Economic factors, particularly higher income levels, facilitate more accessible healthcare services, allowing for a broader spectrum of the population to avail themselves of this contraceptive method. These financial considerations also support ongoing research and development in the field, leading to potential innovations and improvements in IUD technology.

The positively changing cultural attitudes towards reproductive health is contributing to a more open dialogue and acceptance of various contraceptive options, including IUDs. The integration of advanced medical practices and continual professional development among healthcare providers further enhances the region's ability to offer state-of-the-art care.

Competitive Landscape:

The leading companies are investing in research and development (R&D) activities to create new and improved IUDs. These innovations often focus on enhancing effectiveness, reducing side effects, and increasing user comfort. The key players are also exploring new markets and expanding into emerging economies to utilize opportunities in areas where contraceptive methods like IUDs may be less prevalent. To enhance awareness and acceptance of IUDs, the major companies are engaging in educational campaigns by working with healthcare providers and community organizations to provide accurate product information. Furthermore, the top players are working closely with regulatory bodies to ensure that their products comply with local laws and guidelines, maintaining quality and safety. Apart from this, they are also diversifying their portfolio and offering products at various price points, to make IUDs accessible to a broader range of income levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Actavis
  • Bayer
  • Teva Pharmaceuticals
  • Allergan
  • ANI Pharmaceuticals
  • Eurogine
  • OCON Medical
  • Pregna
  • SMB Corporation
  • HLL Lifecare
  • HRA Pharma
  • Besins HealthCare

Key Questions Answered in This Report

  • 1.What was the size of the global intrauterine devices market in 2024?
  • 2.What is the expected growth rate of the global intrauterine devices market during 2025-2033?
  • 3.What are the key factors driving the global intrauterine devices market?
  • 4.What has been the impact of COVID-19 on the global intrauterine devices market?
  • 5.What is the breakup of the global intrauterine devices market based on the product?
  • 6.What are the key regions in the global intrauterine devices market?
  • 7.Who are the key players/companies in the global intrauterine devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intrauterine Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by End-Use
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Hormonal Intrauterine Device
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Copper Intrauterine Device
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by End-Use

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gynaecology Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Community Healthcare
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 Europe
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 North America
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intrauterine Devices Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Actavis
    • 10.3.2 Bayer
    • 10.3.3 Teva Pharmaceuticals
    • 10.3.4 Allergan
    • 10.3.5 ANI Pharmaceuticals
    • 10.3.6 Eurogine
    • 10.3.7 OCON Medical
    • 10.3.8 Pregna
    • 10.3.9 SMB Corporation
    • 10.3.10 HLL Lifecare
    • 10.3.11 HRA Pharma
    • 10.3.12 Besins HealthCare